Lv4
446 积分 2025-10-31 加入
Incremental value of HBcrAg to classify 1582 HBeAg‐negative individuals in chronic infection without liver disease or hepatitis
5个月前
已完结
Droplet digital PCR assay provides intrahepatic HBV cccDNA quantification tool for clinical application
5个月前
已完结
Long-term serological, virological and histological responses to RNA inhibition by ARC-520 in Chinese chronic hepatitis B patients on entecavir treatment
5个月前
已完结
Quantitative Measurement of Serum HBcrAg Can Be Used to Assess the Feasibility of Safe Discontinuation of Antiviral Therapy for Chronic Hepatitis B
5个月前
已完结
First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection
5个月前
已完结
What will it take to cure hepatitis B?
5个月前
已完结
Dynamics of HBV biomarkers during nucleos(t)ide analog treatment: A 14-year study
5个月前
已完结
Factors associated with low hepatitis B surface antigen levels in chronic hepatitis B patients treated with nucleot(s)ide analogs
5个月前
已完结
Hepatitis B virus core‐related antigen (HBcrAg) as a prognostic marker for the development of hepatocellular carcinoma: A mini systematic review of the literature
5个月前
已完结
Getting to HBV Cure – will new biomarkers help?
5个月前
已完结
皖公网安备34019202002308
